Back to results
US 2021/0267983 A1Published application
Combinations of ppar agonists and p38 kinase inhibitors for preventing or treating fibrotic diseases
OwnerAlexander BAUSCH, Matthew WRIGHTinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical combination comprising: (a) a PPAR agonist; (b) a p38 kinase inhibitor; and optionally (c) one or more pharmaceutically acceptable diluents, excipients or carriers for use in a method of preventing or treating fibrotic diseases or disorders in a subject.
Claims15
A pharmaceutical combination comprising:
- (a) a PPAR agonist;
- (b) a p38 kinase inhibitor;
- and optionally
- (c) one or more pharmaceutically acceptable diluents, excipients or carriers for use in a method of preventing or treating fibrotic diseases or disorders in a subject.
1 more element
A kit for use in a method of preventing or treating fibrotic diseases or disorders in a subject, comprising a pharmaceutical combination comprising:
- (a) a PPAR agonist;
- (b) a p38 kinase inhibitor;
- and optionally
- (c) one or more pharmaceutically acceptable diluents, excipients or carriers;
- and instructions for using the kit.
2 more elements
Dependencies are inferred from the claim text.